A groundbreaking deal will make a new HIV prevention drug affordable in over 100 low-income countries, potentially advancing ...
A renowned local researcher says scaling up British Columbia’s HIV strategy could help end the global AIDS pandemic by 2030. Otherwise, U.S. cuts to foreign aid programs could create 6.6 million new ...
Innovator calls on researchers to examine AI symbiosis for HIV By Admire Moyo, ITWeb news editorJohannesburg, 19 Sept 2025A ...
Tick-borne encephalitis virus can infect the nervous system and cause life-threatening illness. Finding the cellular gateway ...
The stock-trading website Raging Bull just gave Cocrystal Pharma, a clinical-stage biotech, a big thumbs up for its ...
Nucleoside reverse transcriptase translocation inhibitors (NRTTIs) are a novel class of antiretroviral agents that inhibit HIV replication by targeting the viral reverse transcriptase enzyme and ...
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...
Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...
A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...
Knowing how to leverage these technologies means we can help set the new standard and inform the next evolution of HIV care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback